Baliling, Christina A.
HRN: 26-40-63 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/26/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/26/2024
01/02/2025
IVTT
4.5g
Q6H
CAP
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes